Impedimed (ASX:IPD) Price-to-Tangible-Book

: 5.17 (As of Today)

View and export this data going back to 2007. Start your Free Trial

As of today (2024-04-19), Impedimed's share price is A$0.093. Impedimed's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.02. Hence, Impedimed's Price to Tangible Book Ratio of today is 5.17.

The historical rank and industry rank for Impedimed's Price-to-Tangible-Book or its related term are showing as below:

ASX:IPD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.77 Med: 5.79 Max: 14.49
Current: 4.65

During the past 13 years, Impedimed's highest Price to Tangible Book Ratio was 14.49. The lowest was 2.77. And the median was 5.79.

ASX:IPD's Price-to-Tangible-Book is ranked worse than
70.31% of 704 companies
in the Medical Devices & Instruments industry
Industry Median: 2.565 vs ASX:IPD: 4.65

A closely related ratio is called PB Ratio. As of today, Impedimed's share price is A$0.093. Impedimed's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.03. Hence, Impedimed's P/B Ratio of today is 3.72.

Impedimed Price-to-Tangible-Book Historical Data

The historical data trend for Impedimed's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

4.23

2.86

8.75

2.77

7.83

Impedimed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book																6.25	2.77	5.27	7.83	8.06

Competitive Comparison

For the Medical Devices subindustry, Impedimed's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Impedimed Price-to-Tangible-Book Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Impedimed's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Impedimed's Price-to-Tangible-Book falls into.

Impedimed Price-to-Tangible-Book Calculation

Impedimed's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.093	/	0.018
	=	5.17

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Impedimed Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Impedimed's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Impedimed (ASX:IPD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (ASX:IPD) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

IPDQF:USA

Address

50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008

Website

https://www.impedimed.com

Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates most of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The Company recognizes revenue from stand alone sale of Legacy Devices and Consumables, Sale of SOZO Device and Software Subscription Services.

Impedimed (ASX:IPD) Headlines

No Headlines